Lee DunatoPublic Health@mander.xyz·7 months agoFDA faces backlash over approval of genetic test for opioid addiction risk(www.nbcnews.com)external-linkarrow-up112arrow-down10message-square2fedilink
arrow-up112arrow-down1external-linkFDA faces backlash over approval of genetic test for opioid addiction risk(www.nbcnews.com)Lee DunatoPublic Health@mander.xyz·7 months agomessage-square2fedilink
minus-squareTacoNotarrow-up4arrow-down0·6 months agolinkfedilink SOLVD Health said in its application that AvertD had demonstrated a sensitivity of about 82% and a specificity of about 79%. Those numbers suggest that roughly 1 in 5 results would be false negatives and roughly 1 in 5 would be false positives. That doesn’t seem very good
minus-squarejaderoarrow-up1arrow-down0·6 months agolinkfedilinkTotal error rate is about 2/5? That’s barely better than a coin flip. “Oh yes, I just got tested for my potential to become an opioid addict. Give me a second to flip a coin: heads I read the report, tails I toss it in the recycle bin.”
That doesn’t seem very good
Total error rate is about 2/5? That’s barely better than a coin flip.
“Oh yes, I just got tested for my potential to become an opioid addict. Give me a second to flip a coin: heads I read the report, tails I toss it in the recycle bin.”